Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients.
暂无分享,去创建一个
A. M. Vågane | D. Naso | Y. Tomino | Hitoshi Suzuki | F. Schena | F. Pesce | V. Ostuni | T. Di Noia | R. Bjørneklett | G. Binetti | M. Diciolla | Eugenio Di Sciascio | H. Suzuki | Tommaso Di Noia | Giulio Binetti
[1] F. Schena,et al. Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.
[2] Michele Rossini,et al. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] K. Kiryluk,et al. Glomerular diseases: emerging tests and therapies for IgA nephropathy. , 2014, Clinical journal of the American Society of Nephrology : CJASN.
[4] Krzysztof Kiryluk,et al. Predicting Progression of IgA Nephropathy: New Clinical Progression Risk Score , 2012, PloS one.
[5] S. Barbour,et al. Risk stratification of patients with IgA nephropathy. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] Sandrine Florquin,et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. , 2009, Kidney international.
[7] L. Bostad,et al. Long-term risk of ESRD in IgAN; validation of Japanese prognostic model in a Norwegian cohort. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] R. Coppo,et al. Factors predicting progression of IgA nephropathies. , 2005, Journal of nephrology.
[9] Tommaso Di Noia,et al. An end stage kidney disease predictor based on an artificial neural networks ensemble , 2013, Expert Syst. Appl..
[10] R. Naumovic,et al. Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[11] F. Schena,et al. Role of let-7b in the regulation of N-acetylgalactosaminyltransferase 2 in IgA nephropathy. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] Fernand,et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. , 2009, Kidney international.
[13] C. Mariat,et al. The use of the Oxford classification of IgA nephropathy to predict renal survival. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[14] J. Berger,et al. [Intercapillary deposits of IgA-IgG]. , 1968, Journal d'urologie et de nephrologie.
[15] Mohamed Ghoneim,et al. Prediction of Graft Survival of Living-Donor Kidney Transplantation: Nomograms or Artificial Neural Networks? , 2008, Transplantation.
[16] D. Cattran,et al. Validation of the Toronto Formula to Predict Progression in IgA Nephropathy , 2008, Nephron Clinical Practice.
[17] Masahiko Ando,et al. A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[18] L. Thibaudin,et al. Predicting the risk for dialysis or death in IgA nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.
[19] B. Chung,et al. The Oxford classification as a predictor of prognosis in patients with IgA nephropathy. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[20] A. Tamakoshi,et al. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] K. Simpson,et al. An artificial neural network can select patients at high risk of developing progressive IgA nephropathy more accurately than experienced nephrologists. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] Michael E Brier,et al. Prediction of delayed renal allograft function using an artificial neural network. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] D. Cattran,et al. Predicting progression in IgA nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] B. Julian,et al. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. , 2011, Kidney international.
[25] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[26] E. Svarstad,et al. Mortality in patients with IgA nephropathy. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] B. Julian,et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. , 2007, Kidney international.